Organization

(DRUGS)- Research Networking Programme is designed as a network of excellent research groups. They collaborate in three different levels defined by a proper terminology:

Working plan 2008-2012

Management (Steering Committee, Evaluation PPP, CFP, etc.)
WorkshopsPhd/postdoc ProgramConferences
Objects
1. Psychochemicals (S. Snelder, Amsterdam)
2. Antibiotics (A. Romero depablos, Madrid)
3. Beta-blockers, cardiacs (C. Timmermann, Manchester)
4. Biological drugs (B. Wahrig, Braunschweig)
Psychochemicals
(Amsterdam, Berlin, Braunschweig, Zurich)
Antibiotics
(Madrid, Manchester, Oslo, Strasbourg)
Cardiacs
(Manchester)
Biological drugs
(Braunschweig, Paris)
Clinical research
(Amsterdam, Berlin, Braunschweig)
Clinical records
(Berlin, Zurich)
Pharmaceutical market
(Paris, Strasbourg, Zurich)
Methods
(Amsterdam, Berlin, Strasbourg, Oslo)
Archives
(London, Berlin, Paris, Strasbourg)
Opening Conference
History of therapeutic agents
Strasbourg / A. Rasmussen, C. Bonah, C. Masutti
Methods
1. Archives (A. Hardy / London)
2. Clinical Records (U. Kloppel / Berlin)
1. Expertise seminar
Standardisation as analytical frame (J-P. Gaudilliere / Paris)
Thematic analysis
1. Clinical research (A. K. Lie / Oslo)
2. Risk & crisis (B. Bernet / Zurich)
2. Expertise seminar
Standardizing and the public (J. Simon / Lyon)
Final conference
Globalisation and regulation (A. Huntelmann, Berlin)
Open Access Database